{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T23:04:07Z","timestamp":1778195047172,"version":"3.51.4"},"reference-count":59,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2007,3,31]],"date-time":"2007-03-31T00:00:00Z","timestamp":1175299200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Alcoholism Clin &amp;amp; Exp Res"],"published-print":{"date-parts":[[2007,5]]},"abstract":"<jats:p><jats:bold>Background: <\/jats:bold> Coinfection of human immunodeficiency virus (HIV) and hepatitis C virus (HCV) is a substantial medical and public health concern due to its increasing prevalence and complex patient management. Alcohol use may worsen HCV\u2010related liver disease and interfere with adherence to antiretroviral therapy (ART) and medical care. We therefore studied the association between HCV infection and markers of HIV disease progression in adults with alcohol problems.<\/jats:p><jats:p><jats:bold>Methods: <\/jats:bold> This is a longitudinal study of 396 HIV\u2010infected persons with alcohol problems, 199 (50%) of whom were coinfected with HCV (positive HCV RNA test). CD4 cell counts and HIV RNA levels were assessed at baseline and then every 6 months for up to 42 months. Hepatitis C virus RNA status was determined at study enrollment. We examined the relationship between HCV infection and laboratory markers of HIV progression (CD4 cell count and log<jats:sub>10<\/jats:sub> HIV RNA) by fitting multivariable longitudinal regression models for each outcome.<\/jats:p><jats:p><jats:bold>Results: <\/jats:bold> Among subjects who were adherent to ART, the presence of HCV infection was associated with a lower CD4 cell count (adjusted mean difference \u221246.0 cells\/<jats:italic>\u03bc<\/jats:italic>L, <jats:italic>p<\/jats:italic>=0.03). There was no association observed between HCV infection and CD4 cell count among those not adherent to ART or those not taking ART. No significant association was observed between HCV infection and HIV RNA regardless of ART status.<\/jats:p><jats:p><jats:bold>Conclusions: <\/jats:bold> Hepatitis C virus infection has an adverse effect on CD4 cell count in patients with alcohol problems who are adherent to ART. Addressing HCV coinfection among these patients may confer additional immunologic benefit for this patient population.<\/jats:p>","DOI":"10.1111\/j.1530-0277.2007.00381.x","type":"journal-article","created":{"date-parts":[[2007,4,25]],"date-time":"2007-04-25T19:44:10Z","timestamp":1177530250000},"page":"829-836","source":"Crossref","is-referenced-by-count":17,"title":["Impact of Hepatitis C on HIV Progression in Adults With Alcohol Problems"],"prefix":"10.1111","volume":"31","author":[{"given":"Debbie M.","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard","family":"Libman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Vidaver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie K.","family":"Alperen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Saitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey H.","family":"Samet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,3,31]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2005.03.003"},{"key":"e_1_2_6_3_1","first-page":"1507","article-title":"Hepatitis C virus coinfection increases mortality in HIV\u2010infected patients in the highly active antiretroviral therapy era","volume":"39","author":"Anderson KB","year":"2004","journal-title":"data from the HIV Atlanta VA Cohort Study"},{"key":"e_1_2_6_4_1","first-page":"613","article-title":"Effects of hepatitis C virus coinfection on survival in veterans with HIV treated with highly active antiretroviral therapy","volume":"39","author":"Backus LI","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.2003.00808.x"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.80882-0"},{"key":"e_1_2_6_7_1","first-page":"3365","article-title":"Hepatitis C in patients with human immunodeficiency virus infection","volume":"160","author":"Bonacini M","year":"2000","journal-title":"diagnosis, natural history, meta-analysis of sexual and vertical transmission, and therapeutic issues"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.045202"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1086\/498908"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-115-10-774"},{"key":"e_1_2_6_11_1","first-page":"255","article-title":"Self\u2010reported adherence to antiretroviral medications among participants in HIV clinical trials","volume":"12","author":"Chesney MA","year":"2000","journal-title":"the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG)"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032653"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200209270-00008"},{"key":"e_1_2_6_14_1","first-page":"265","article-title":"Effect of a single ethanol exposure on HIV replication in human lymphocytes","volume":"45","author":"Cook RT","year":"1997","journal-title":"J Invest Med"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.162.18.2125"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/172.6.1503"},{"key":"e_1_2_6_17_1","first-page":"175","article-title":"Survival in hepatitis C and HIV co\u2010infection","volume":"3","author":"El\u2010Serag HB","year":"2005","journal-title":"a cohort study of hospitalized veterans"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840360621"},{"key":"e_1_2_6_19_1","first-page":"97","article-title":"Hepatitis C virus and human immunodeficiency virus coinfection in an urban population","volume":"36","author":"Fleming CA","year":"2003","journal-title":"low eligibility for interferon treatment"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3956(75)90026-6"},{"key":"e_1_2_6_21_1","first-page":"1800","article-title":"Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV\u20101 and hepatitis C virus coinfection","volume":"356","author":"Greub G","year":"2000","journal-title":"the Swiss HIV cohort study"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14307-3"},{"key":"e_1_2_6_23_1","first-page":"2187","article-title":"CD4 T\u2010lymphocyte recovery in individuals with advanced HIV\u20101 infection receiving potent antiretroviral therapy for 4 years","volume":"163","author":"Kaufmann GR","year":"2003","journal-title":"the Swiss HIV Cohort Study"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200409030-00013"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlr.0000163652.91463.b4"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/mpr.47"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200307010-00011"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1089\/08892220260139495"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2005.01.015"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.2307\/2529876"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200405210-00010"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01691112"},{"key":"e_1_2_6_33_1","first-page":"1121","article-title":"The CAGE questionnaire","volume":"131","author":"Mayfield D","year":"1974","journal-title":"validation of a new alcoholism screening instrument"},{"key":"e_1_2_6_34_1","volume-title":"The Physician's Guide to Helping Patients With Alcohol Problems","author":"National Institute on Alcohol Abuse and Alcoholism","year":"1995"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1086\/508355"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-199504120-00003"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8278(95)80027-1"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199804000-00006"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.2003.00804.x"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14844-1"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200207050-00007"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1988.01800360017003"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1086\/432762"},{"key":"e_1_2_6_44_1","first-page":"77","article-title":"Understanding delay to medical care for HIV infection","volume":"15","author":"Samet JH","year":"2001","journal-title":"the long-term non-presenter"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ALC.0000122103.74491.78"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.155.15.1629"},{"key":"e_1_2_6_47_1","first-page":"151","article-title":"Detecting alcohol problems in HIV\u2010infected patients","volume":"20","author":"Samet JH","year":"2004","journal-title":"use of the CAGE questionnaire"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(99)00393-9"},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2005.09.012"},{"key":"e_1_2_6_50_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4612-0357-5_3"},{"key":"e_1_2_6_51_1","first-page":"221","article-title":"Care of patients with chronic hepatitis B and HIV co\u2010infection","volume":"19","author":"Soriano V","year":"2005","journal-title":"recommendations from an HIV-HBV International Panel"},{"key":"e_1_2_6_52_1","first-page":"150","article-title":"Hepatitis C in the HIV (human immunodeficiency virus) Atlanta V.A. (Veterans Affairs Medical Center) Cohort Study (HAVACS)","volume":"29","author":"Staples CT","year":"1999","journal-title":"the effect of coinfection on survival"},{"key":"e_1_2_6_53_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.2.199"},{"key":"e_1_2_6_54_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-138-3-200302040-00012"},{"key":"e_1_2_6_55_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.1.74"},{"key":"e_1_2_6_56_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.38.2.575-577.2000"},{"key":"e_1_2_6_57_1","first-page":"1180","article-title":"A hepatitis C virus\u2010encoded, nonstructural protein (NS3) triggers dysfunction and apoptosis in lymphocytes","volume":"76","author":"Thoren F","year":"2004","journal-title":"role of NADPH oxidase-derived oxygen radicals"},{"key":"e_1_2_6_58_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa040842"},{"key":"e_1_2_6_59_1","first-page":"1481","article-title":"Impact of hepatitis C virus coinfection on response to highly active antiretroviral therapy and outcome in HIV\u2010infected individuals","volume":"42","author":"Weis N","year":"2006","journal-title":"a nationwide cohort study"},{"key":"e_1_2_6_60_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/20.4.768"}],"container-title":["Alcoholism: Clinical and Experimental Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1530-0277.2007.00381.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1530-0277.2007.00381.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T11:34:43Z","timestamp":1697110483000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1530-0277.2007.00381.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3,31]]},"references-count":59,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["10.1111\/j.1530-0277.2007.00381.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1530-0277.2007.00381.x","archive":["Portico"],"relation":{},"ISSN":["0145-6008","1530-0277"],"issn-type":[{"value":"0145-6008","type":"print"},{"value":"1530-0277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3,31]]}}}